Abstract
Previous studies have clearly demonstrated that polyisobutylcyanoacrylate (PIBCA) doxorubicin-loaded nanoparticles (NS-Dox PIBCA) can overcome the resistance of P388/ADR cells. In the present paper, we found that overcoming multidrug resistance with the aid of doxorubicin (Dox) loaded onto these nanoparticles was associated with an increased intracellular drug content. Indeed, after a 6-h incubation period, the amount of cell-associated drug was 5 times higher when the cells were incubated with NS-Dox PIBCA as compared with free Dox. Further experiments, such as uptake studies in the presence of cytochalasin chalasin B or efflux studies, indicated a possible mechanism of nanoparticle/cell interaction. These results suggested that nanoparticles did not enter the cells by an endocytic process, in contrast to a previous hypothesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baurain R, Zenebergh A, Trouet A (1979) Cellular uptake and metabolism of daunorubicin as determined by high-performance liquid chromatography. Anal Biochem 94:112–116
Chen CJ, Chin JE, Ueda K, Clark DF, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdrI (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381–389
Couyreur P, Tulkens P, Roland M, Trouet A, Speiser P (1977) Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett 84:323–326
Couvreur P, Kante B, Rolland M, Guiot P, Bauduin P, Speiser P, et al (1979) Polyalkylcyanoacrylate nanocapsules as potential lysomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 31:331–332
Cuvier C, Roblot-Treupel L, Chevillard S, Millot JM, Mainfait M, Bastian G, Couvreur P, Poupon M-F (1992) Doxorubicin loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol 44:509–517
Dubernet C, Nemati F, Colin De Verdière A, Poupon MF, Couvreur P (1992) Efficacy of polyakylcyanocrylate nanospheres loaded with doxorubicin in the reversion of multidrug resistant cell lines. Clin Exp Metastasis 10 [Supl]:105
Guise V, Jaffray P, Delattre J, Puisieux F, Adolphe M, Couvreur P (1987) Comparative cell uptake of propidium iodide associated with liposomes or nanoparticles. Cell Mol Biol 33:397–405
Isabella P de, Capracino G, Zinino F (1991) The role of topoisomerase II in drug resistance. Life Sci 48:2195–2205
Juranka PF, Zastawany RL, Ling V (1989) P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB 3:2583–2592
Lee FYF, Sciandra J, Siemann DW (1989) A study of the mechanism of resistance of Adriamycin in vivo. Biochem Pharmacol 38:3697–3705
Lherm C, Muller RH, Puisieux F, Couvreur P (1992) Alkylcyanoacrylate drug carriers. II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm 84:13–22
Lowry OH, Rosenbrough NJ, Foarr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265
Thierry AR, Dritschilo A, Rahman A (1992) Effect of liposomes on P-glycoprotein function in multidrug resistant cells. Biochem Biophys Res Commun 187:1098–1105
Tritton TR, Yee G (1982) The anticancer agent Adriamycin can be actively cytotoxic without entering cells. Science 217:248–250
Tritton TR, Yee G, Wingard LB (1983) Immobilized Adriamycin: a tool for separating cell surface from intracellular mechanisms. Fed Proc 42:284–287
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Verdière, A.C., Dubernet, C., Nemati, F. et al. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother. Pharmacol. 33, 504–508 (1994). https://doi.org/10.1007/BF00686509
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686509